

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 5.82124966 |
| 2 | hemidesmosome assembly (GO:0031581) | 5.41012051 |
| 3 | cell adhesion mediated by integrin (GO:0033627) | 4.94941575 |
| 4 | cell aggregation (GO:0098743) | 4.62026140 |
| 5 | cartilage condensation (GO:0001502) | 4.62026140 |
| 6 | glucuronate metabolic process (GO:0019585) | 4.57478417 |
| 7 | uronic acid metabolic process (GO:0006063) | 4.57478417 |
| 8 | cellular glucuronidation (GO:0052695) | 4.53462013 |
| 9 | positive regulation of extracellular matrix organization (GO:1903055) | 4.46387669 |
| 10 | surfactant homeostasis (GO:0043129) | 4.27311456 |
| 11 | notochord development (GO:0030903) | 4.25335289 |
| 12 | COPI coating of Golgi vesicle (GO:0048205) | 4.15220656 |
| 13 | Golgi transport vesicle coating (GO:0048200) | 4.15220656 |
| 14 | keratan sulfate catabolic process (GO:0042340) | 4.02050314 |
| 15 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.96631589 |
| 16 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.94420083 |
| 17 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.87425077 |
| 18 | protein localization to endosome (GO:0036010) | 3.72883661 |
| 19 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.70975618 |
| 20 | chondrocyte development (GO:0002063) | 3.69126279 |
| 21 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.66098383 |
| 22 | limb bud formation (GO:0060174) | 3.55288204 |
| 23 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.55229171 |
| 24 | regulation of water loss via skin (GO:0033561) | 3.49658708 |
| 25 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.45207248 |
| 26 | cellular response to interferon-alpha (GO:0035457) | 3.42105624 |
| 27 | membrane raft organization (GO:0031579) | 3.40356791 |
| 28 | cell-substrate junction assembly (GO:0007044) | 3.39798045 |
| 29 | chemical homeostasis within a tissue (GO:0048875) | 3.37905657 |
| 30 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.35870146 |
| 31 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.34118955 |
| 32 | epithelial cell-cell adhesion (GO:0090136) | 3.31961918 |
| 33 | keratinocyte proliferation (GO:0043616) | 3.30609985 |
| 34 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.26860706 |
| 35 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.25777500 |
| 36 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.24859458 |
| 37 | positive regulation of interferon-alpha production (GO:0032727) | 3.24218701 |
| 38 | diterpenoid biosynthetic process (GO:0016102) | 3.23711655 |
| 39 | protein retention in ER lumen (GO:0006621) | 3.23149780 |
| 40 | endothelial cell morphogenesis (GO:0001886) | 3.21658577 |
| 41 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.16917251 |
| 42 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.15837673 |
| 43 | negative regulation of fibrinolysis (GO:0051918) | 3.15037423 |
| 44 | superoxide anion generation (GO:0042554) | 3.12625055 |
| 45 | reactive oxygen species biosynthetic process (GO:1903409) | 3.06922399 |
| 46 | collagen fibril organization (GO:0030199) | 3.06434024 |
| 47 | response to peptidoglycan (GO:0032494) | 3.06379355 |
| 48 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.05631660 |
| 49 | regulation of interferon-alpha production (GO:0032647) | 3.04664791 |
| 50 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.04392586 |
| 51 | regulation of extracellular matrix organization (GO:1903053) | 3.02410023 |
| 52 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.01009859 |
| 53 | modulation by symbiont of host immune response (GO:0052553) | 3.01009859 |
| 54 | positive regulation by symbiont of host defense response (GO:0052509) | 3.01009859 |
| 55 | modulation by symbiont of host defense response (GO:0052031) | 3.01009859 |
| 56 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.01009859 |
| 57 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.01009859 |
| 58 | multicellular organismal water homeostasis (GO:0050891) | 3.00172600 |
| 59 | positive regulation of p38MAPK cascade (GO:1900745) | 2.98655948 |
| 60 | hypotonic response (GO:0006971) | 2.97493714 |
| 61 | xenobiotic catabolic process (GO:0042178) | 2.96817918 |
| 62 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.93144389 |
| 63 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.92417696 |
| 64 | establishment of skin barrier (GO:0061436) | 2.92163053 |
| 65 | regulation of extracellular matrix disassembly (GO:0010715) | 2.89959162 |
| 66 | gap junction assembly (GO:0016264) | 2.88486248 |
| 67 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.88142561 |
| 68 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.85265264 |
| 69 | endocardial cushion morphogenesis (GO:0003203) | 2.85134083 |
| 70 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.83984287 |
| 71 | protein carboxylation (GO:0018214) | 2.83816678 |
| 72 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.83816678 |
| 73 | mesodermal cell differentiation (GO:0048333) | 2.83395894 |
| 74 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.82130293 |
| 75 | lung vasculature development (GO:0060426) | 2.82016606 |
| 76 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.80396689 |
| 77 | neutrophil activation involved in immune response (GO:0002283) | 2.78897152 |
| 78 | mammary gland epithelial cell proliferation (GO:0033598) | 2.78364806 |
| 79 | wound healing, spreading of epidermal cells (GO:0035313) | 2.77613137 |
| 80 | cyclooxygenase pathway (GO:0019371) | 2.75978903 |
| 81 | muscle cell migration (GO:0014812) | 2.75871655 |
| 82 | endodermal cell differentiation (GO:0035987) | 2.75125108 |
| 83 | iron ion import (GO:0097286) | 2.74984048 |
| 84 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.74878889 |
| 85 | regulation of metalloenzyme activity (GO:0048552) | 2.74537608 |
| 86 | negative regulation of cytokine secretion (GO:0050710) | 2.74166333 |
| 87 | regulation of plasminogen activation (GO:0010755) | 2.73069263 |
| 88 | negative regulation of lipid storage (GO:0010888) | 2.71440793 |
| 89 | regulation of fever generation (GO:0031620) | 2.70865979 |
| 90 | cellular copper ion homeostasis (GO:0006878) | 2.70343724 |
| 91 | fibrinolysis (GO:0042730) | 2.69919743 |
| 92 | decidualization (GO:0046697) | 2.69055952 |
| 93 | prostanoid metabolic process (GO:0006692) | 2.68767663 |
| 94 | prostaglandin metabolic process (GO:0006693) | 2.68767663 |
| 95 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.68669775 |
| 96 | heart valve morphogenesis (GO:0003179) | 2.68443252 |
| 97 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.67335366 |
| 98 | regulation of mononuclear cell migration (GO:0071675) | 2.66960982 |
| 99 | bone remodeling (GO:0046849) | 2.66942684 |
| 100 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.66704882 |
| 101 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.66614815 |
| 102 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.61291282 |
| 103 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.61027408 |
| 104 | positive regulation of male gonad development (GO:2000020) | 2.60779218 |
| 105 | regulation of transforming growth factor beta production (GO:0071634) | 2.59126095 |
| 106 | detection of molecule of bacterial origin (GO:0032490) | 2.58120409 |
| 107 | positive regulation of type 2 immune response (GO:0002830) | 2.57265884 |
| 108 | barbed-end actin filament capping (GO:0051016) | 2.56446102 |
| 109 | regulation of interleukin-8 secretion (GO:2000482) | 2.56217397 |
| 110 | substrate-dependent cell migration (GO:0006929) | 2.55234681 |
| 111 | tight junction assembly (GO:0070830) | 2.53157145 |
| 112 | response to nitrosative stress (GO:0051409) | 2.52737932 |
| 113 | regulation of male gonad development (GO:2000018) | 2.52424103 |
| 114 | regulation of fibrinolysis (GO:0051917) | 2.51516556 |
| 115 | protein hydroxylation (GO:0018126) | 2.51335157 |
| 116 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.51242486 |
| 117 | glomerular visceral epithelial cell development (GO:0072015) | 2.50926663 |
| 118 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.49594157 |
| 119 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.49272951 |
| 120 | apoptotic cell clearance (GO:0043277) | 2.49118223 |
| 121 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.48982024 |
| 122 | inflammatory response to antigenic stimulus (GO:0002437) | 2.48547866 |
| 123 | regulation of phospholipase A2 activity (GO:0032429) | 2.47647341 |
| 124 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.46689489 |
| 125 | positive regulation of heat generation (GO:0031652) | 2.45921308 |
| 126 | water homeostasis (GO:0030104) | 2.45883983 |
| 127 | negative regulation of coagulation (GO:0050819) | 2.45482663 |
| 128 | response to interferon-alpha (GO:0035455) | 2.45216608 |
| 129 | virion attachment to host cell (GO:0019062) | 2.44549676 |
| 130 | adhesion of symbiont to host cell (GO:0044650) | 2.44549676 |
| 131 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.43866871 |
| 132 | regulation of heat generation (GO:0031650) | 2.43139509 |
| 133 | negative regulation of complement activation (GO:0045916) | 2.42139428 |
| 134 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.42075395 |
| 135 | regulation of complement activation (GO:0030449) | 2.40861193 |
| 136 | interferon-gamma secretion (GO:0072643) | 2.40724026 |
| 137 | negative regulation of fatty acid transport (GO:2000192) | 2.40413930 |
| 138 | negative regulation of protein activation cascade (GO:2000258) | 2.40181346 |
| 139 | focal adhesion assembly (GO:0048041) | 2.39917411 |
| 140 | cell-substrate adherens junction assembly (GO:0007045) | 2.39917411 |
| 141 | regulation of vitamin metabolic process (GO:0030656) | 2.39894706 |
| 142 | membrane protein ectodomain proteolysis (GO:0006509) | 2.39775900 |
| 143 | oligosaccharide catabolic process (GO:0009313) | 2.39771696 |
| 144 | eosinophil chemotaxis (GO:0048245) | 2.39097815 |
| 145 | response to muramyl dipeptide (GO:0032495) | 2.38966173 |
| 146 | regulation of protein activation cascade (GO:2000257) | 2.38929223 |
| 147 | peptidyl-proline hydroxylation (GO:0019511) | 2.37825083 |
| 148 | wound healing, spreading of cells (GO:0044319) | 2.37550349 |
| 149 | adherens junction assembly (GO:0034333) | 2.37481771 |
| 150 | negative regulation of protein secretion (GO:0050709) | 2.36181860 |
| 151 | negative regulation of blood coagulation (GO:0030195) | 2.35772717 |
| 152 | negative regulation of hemostasis (GO:1900047) | 2.35772717 |
| 153 | negative regulation of wound healing (GO:0061045) | 2.35588552 |
| 154 | mesenchyme morphogenesis (GO:0072132) | 2.35504017 |
| 155 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.35198445 |
| 156 | endocytic recycling (GO:0032456) | 2.34899339 |
| 157 | glycosphingolipid catabolic process (GO:0046479) | 2.34418753 |
| 158 | low-density lipoprotein particle remodeling (GO:0034374) | 2.34242667 |
| 159 | prostanoid biosynthetic process (GO:0046457) | 2.33782306 |
| 160 | prostaglandin biosynthetic process (GO:0001516) | 2.33782306 |
| 161 | positive regulation of interferon-beta production (GO:0032728) | 2.32815172 |
| 162 | granulocyte activation (GO:0036230) | 2.32426394 |
| 163 | adhesion of symbiont to host (GO:0044406) | 2.32207582 |
| 164 | establishment of apical/basal cell polarity (GO:0035089) | 2.31934064 |
| 165 | regulation of cardioblast differentiation (GO:0051890) | 2.31583905 |
| 166 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.30285776 |
| 167 | neural crest cell development (GO:0014032) | 2.30210387 |
| 168 | lipoxygenase pathway (GO:0019372) | 2.29259971 |
| 169 | pinocytosis (GO:0006907) | 2.28924283 |
| 170 | regulation of superoxide anion generation (GO:0032928) | 2.27428220 |
| 171 | folic acid transport (GO:0015884) | 2.26737179 |
| 172 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.26397232 |
| 173 | macrophage activation involved in immune response (GO:0002281) | 2.26143287 |
| 174 | phospholipid efflux (GO:0033700) | 2.25746066 |
| 175 | microglial cell activation (GO:0001774) | 2.25694492 |
| 176 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.25270053 |
| 177 | regulation of cholesterol esterification (GO:0010872) | 2.25181561 |
| 178 | indole-containing compound catabolic process (GO:0042436) | 2.24879909 |
| 179 | indolalkylamine catabolic process (GO:0046218) | 2.24879909 |
| 180 | tryptophan catabolic process (GO:0006569) | 2.24879909 |
| 181 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.24655770 |
| 182 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.24316569 |
| 183 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.23768887 |
| 184 | heart valve formation (GO:0003188) | 2.23377175 |
| 185 | skin morphogenesis (GO:0043589) | 2.23250257 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.02670709 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.94015893 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.38436074 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.01436935 |
| 5 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.05887775 |
| 6 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.04410991 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.99542151 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.71964099 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.70043143 |
| 10 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.67986506 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.59191963 |
| 12 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.48153526 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.43400025 |
| 14 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.41419625 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.40832580 |
| 16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.40632524 |
| 17 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.34281905 |
| 18 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 2.31758285 |
| 19 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.18821701 |
| 20 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.17943482 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.15205871 |
| 22 | CJUN_26792858_Chip-Seq_BT549_Human | 2.09565337 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.09447185 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.04734995 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.01016065 |
| 26 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.96111054 |
| 27 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.96084672 |
| 28 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.90556295 |
| 29 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.90013809 |
| 30 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.88358975 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.87747155 |
| 32 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.85822912 |
| 33 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.85822912 |
| 34 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.85339013 |
| 35 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.85339013 |
| 36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.85323454 |
| 37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.82613679 |
| 38 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.79529632 |
| 39 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.79037534 |
| 40 | ATF3_27146783_Chip-Seq_COLON_Human | 1.76959598 |
| 41 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.76232170 |
| 42 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.75784165 |
| 43 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70667713 |
| 44 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.68668659 |
| 45 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.67292202 |
| 46 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.66375005 |
| 47 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.66265258 |
| 48 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60639414 |
| 49 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.58580188 |
| 50 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.58248903 |
| 51 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55547653 |
| 52 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.51920163 |
| 53 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51587875 |
| 54 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.51565761 |
| 55 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.49962790 |
| 56 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44819332 |
| 57 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44237753 |
| 58 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.42235888 |
| 59 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.40492248 |
| 60 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.40082845 |
| 61 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.38235814 |
| 62 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.38003072 |
| 63 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.36667562 |
| 64 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.35616104 |
| 65 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.33443166 |
| 66 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32966767 |
| 67 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.32662743 |
| 68 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.31742511 |
| 69 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.29324466 |
| 70 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28332816 |
| 71 | RXR_22108803_ChIP-Seq_LS180_Human | 1.26602624 |
| 72 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.25629607 |
| 73 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.25081984 |
| 74 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23181013 |
| 75 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20357013 |
| 76 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.19848706 |
| 77 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18984568 |
| 78 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.18524455 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18276169 |
| 80 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.17315420 |
| 81 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14743743 |
| 82 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13267189 |
| 83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.13102523 |
| 84 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.12628016 |
| 85 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.12006965 |
| 86 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.11294827 |
| 87 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.09045938 |
| 88 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.08479564 |
| 89 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.08272813 |
| 90 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08134884 |
| 91 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.07881647 |
| 92 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07353962 |
| 93 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.06969933 |
| 94 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.06245399 |
| 95 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.06238959 |
| 96 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05525491 |
| 97 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.05223263 |
| 98 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05046620 |
| 99 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.04946753 |
| 100 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04448878 |
| 101 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04267118 |
| 102 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.03865883 |
| 103 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03622215 |
| 104 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.03612467 |
| 105 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.03278801 |
| 106 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02715541 |
| 107 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02715541 |
| 108 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.02408081 |
| 109 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.02189019 |
| 110 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01744494 |
| 111 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.96985688 |
| 112 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.94814666 |
| 113 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.94325732 |
| 114 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.93928182 |
| 115 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.92970753 |
| 116 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.92583277 |
| 117 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.89996242 |
| 118 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89923966 |
| 119 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89698071 |
| 120 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.89234937 |
| 121 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.88692750 |
| 122 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.88513119 |
| 123 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.85117474 |
| 124 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.84859396 |
| 125 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.83648607 |
| 126 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.81798123 |
| 127 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.81370412 |
| 128 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.80603654 |
| 129 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.79524346 |
| 130 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.78130707 |
| 131 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.76790721 |
| 132 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.76141254 |
| 133 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.74919331 |
| 134 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71170470 |
| 135 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70924199 |
| 136 | TP53_16413492_ChIP-PET_HCT116_Human | 0.67890843 |
| 137 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.67151253 |
| 138 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.66824331 |
| 139 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.66479435 |
| 140 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66207369 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 3.19553518 |
| 2 | MP0003195_calcinosis | 2.99711869 |
| 3 | MP0003436_decreased_susceptibility_to | 2.95952017 |
| 4 | MP0002282_abnormal_trachea_morphology | 2.75848527 |
| 5 | MP0010352_gastrointestinal_tract_polyps | 2.72870140 |
| 6 | MP0002933_joint_inflammation | 2.68337014 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 2.54559022 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.45348768 |
| 9 | MP0003941_abnormal_skin_development | 2.40664882 |
| 10 | MP0002254_reproductive_system_inflammat | 2.36039575 |
| 11 | MP0001533_abnormal_skeleton_physiology | 2.32798036 |
| 12 | MP0002877_abnormal_melanocyte_morpholog | 2.22144745 |
| 13 | MP0009780_abnormal_chondrocyte_physiolo | 2.22024401 |
| 14 | MP0005257_abnormal_intraocular_pressure | 2.20850911 |
| 15 | MP0005503_abnormal_tendon_morphology | 2.11409164 |
| 16 | MP0005275_abnormal_skin_tensile | 2.03857563 |
| 17 | MP0008004_abnormal_stomach_pH | 2.01592644 |
| 18 | MP0008438_abnormal_cutaneous_collagen | 2.00167457 |
| 19 | MP0003724_increased_susceptibility_to | 1.99619474 |
| 20 | MP0005390_skeleton_phenotype | 1.95892994 |
| 21 | MP0004782_abnormal_surfactant_physiolog | 1.95852805 |
| 22 | MP0001542_abnormal_bone_strength | 1.94874392 |
| 23 | MP0001835_abnormal_antigen_presentation | 1.92969433 |
| 24 | MP0003186_abnormal_redox_activity | 1.92618104 |
| 25 | MP0004264_abnormal_extraembryonic_tissu | 1.92491368 |
| 26 | MP0001853_heart_inflammation | 1.86267243 |
| 27 | MP0006054_spinal_hemorrhage | 1.82374693 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.81900900 |
| 29 | MP0000163_abnormal_cartilage_morphology | 1.78575951 |
| 30 | MP0009840_abnormal_foam_cell | 1.78019003 |
| 31 | MP0010678_abnormal_skin_adnexa | 1.77321723 |
| 32 | MP0004134_abnormal_chest_morphology | 1.76806934 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.68855309 |
| 34 | MP0000579_abnormal_nail_morphology | 1.64306518 |
| 35 | MP0009250_abnormal_appendicular_skeleto | 1.60600696 |
| 36 | MP0005623_abnormal_meninges_morphology | 1.60149894 |
| 37 | MP0009764_decreased_sensitivity_to | 1.59791699 |
| 38 | MP0000762_abnormal_tongue_morphology | 1.59119632 |
| 39 | MP0005501_abnormal_skin_physiology | 1.58663602 |
| 40 | MP0002419_abnormal_innate_immunity | 1.58443115 |
| 41 | MP0002060_abnormal_skin_morphology | 1.58141353 |
| 42 | MP0009384_cardiac_valve_regurgitation | 1.57791552 |
| 43 | MP0005360_urolithiasis | 1.57452948 |
| 44 | MP0005508_abnormal_skeleton_morphology | 1.55922414 |
| 45 | MP0009785_altered_susceptibility_to | 1.54832103 |
| 46 | MP0005085_abnormal_gallbladder_physiolo | 1.49125739 |
| 47 | MP0005451_abnormal_body_composition | 1.47633258 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.46692228 |
| 49 | * MP0003091_abnormal_cell_migration | 1.46114324 |
| 50 | MP0003279_aneurysm | 1.45639022 |
| 51 | MP0001849_ear_inflammation | 1.43602561 |
| 52 | MP0005164_abnormal_response_to | 1.43278636 |
| 53 | MP0010030_abnormal_orbit_morphology | 1.42406752 |
| 54 | MP0006082_CNS_inflammation | 1.42373381 |
| 55 | MP0000858_altered_metastatic_potential | 1.42145895 |
| 56 | MP0002115_abnormal_skeleton_extremities | 1.41159527 |
| 57 | MP0005000_abnormal_immune_tolerance | 1.37469442 |
| 58 | MP0005165_increased_susceptibility_to | 1.37359154 |
| 59 | MP0000467_abnormal_esophagus_morphology | 1.37053850 |
| 60 | MP0000537_abnormal_urethra_morphology | 1.35207942 |
| 61 | MP0002098_abnormal_vibrissa_morphology | 1.30383392 |
| 62 | MP0001790_abnormal_immune_system | 1.30248384 |
| 63 | MP0005387_immune_system_phenotype | 1.30248384 |
| 64 | MP0004019_abnormal_vitamin_homeostasis | 1.30193459 |
| 65 | MP0002113_abnormal_skeleton_development | 1.28841571 |
| 66 | MP0000343_altered_response_to | 1.28443494 |
| 67 | MP0003300_gastrointestinal_ulcer | 1.28383774 |
| 68 | * MP0005023_abnormal_wound_healing | 1.26184601 |
| 69 | MP0002295_abnormal_pulmonary_circulatio | 1.23680644 |
| 70 | MP0003795_abnormal_bone_structure | 1.22124771 |
| 71 | MP0008875_abnormal_xenobiotic_pharmacok | 1.20624230 |
| 72 | MP0000627_abnormal_mammary_gland | 1.18864464 |
| 73 | MP0002896_abnormal_bone_mineralization | 1.16598803 |
| 74 | MP0010368_abnormal_lymphatic_system | 1.16382065 |
| 75 | MP0000566_synostosis | 1.15327750 |
| 76 | MP0003448_altered_tumor_morphology | 1.14607516 |
| 77 | MP0010771_integument_phenotype | 1.14361753 |
| 78 | MP0001958_emphysema | 1.14320937 |
| 79 | MP0001216_abnormal_epidermal_layer | 1.12503304 |
| 80 | MP0005025_abnormal_response_to | 1.12488484 |
| 81 | MP0003075_altered_response_to | 1.10418246 |
| 82 | MP0003453_abnormal_keratinocyte_physiol | 1.10258938 |
| 83 | MP0002796_impaired_skin_barrier | 1.09925340 |
| 84 | MP0004510_myositis | 1.06981333 |
| 85 | MP0005166_decreased_susceptibility_to | 1.06799436 |
| 86 | MP0000383_abnormal_hair_follicle | 1.06460478 |
| 87 | MP0008469_abnormal_protein_level | 1.06075502 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 1.01708079 |
| 89 | MP0004272_abnormal_basement_membrane | 1.01550487 |
| 90 | MP0004947_skin_inflammation | 1.00499781 |
| 91 | MP0001346_abnormal_lacrimal_gland | 0.99958929 |
| 92 | MP0001666_abnormal_nutrient_absorption | 0.98742189 |
| 93 | MP0002138_abnormal_hepatobiliary_system | 0.98191698 |
| 94 | MP0003303_peritoneal_inflammation | 0.96806733 |
| 95 | MP0002168_other_aberrant_phenotype | 0.95776146 |
| 96 | MP0001177_atelectasis | 0.95447279 |
| 97 | MP0001881_abnormal_mammary_gland | 0.95439214 |
| 98 | MP0001845_abnormal_inflammatory_respons | 0.94801319 |
| 99 | MP0004381_abnormal_hair_follicle | 0.94335923 |
| 100 | MP0002452_abnormal_antigen_presenting | 0.94193197 |
| 101 | MP0005365_abnormal_bile_salt | 0.93861089 |
| 102 | MP0002136_abnormal_kidney_physiology | 0.92791996 |
| 103 | MP0002405_respiratory_system_inflammati | 0.92689016 |
| 104 | MP0000678_abnormal_parathyroid_gland | 0.91362089 |
| 105 | MP0005083_abnormal_biliary_tract | 0.89268126 |
| 106 | MP0005076_abnormal_cell_differentiation | 0.89124605 |
| 107 | MP0001243_abnormal_dermal_layer | 0.88928347 |
| 108 | MP0003755_abnormal_palate_morphology | 0.87058774 |
| 109 | MP0010155_abnormal_intestine_physiology | 0.86580586 |
| 110 | MP0002163_abnormal_gland_morphology | 0.86138863 |
| 111 | MP0009053_abnormal_anal_canal | 0.86038246 |
| 112 | MP0003191_abnormal_cellular_cholesterol | 0.85652560 |
| 113 | MP0003136_yellow_coat_color | 0.85304623 |
| 114 | MP0005409_darkened_coat_color | 0.84741347 |
| 115 | MP0005197_abnormal_uvea_morphology | 0.84254567 |
| 116 | * MP0003566_abnormal_cell_adhesion | 0.84245893 |
| 117 | MP0002089_abnormal_postnatal_growth/wei | 0.83634510 |
| 118 | MP0003690_abnormal_glial_cell | 0.83368466 |
| 119 | MP0000733_abnormal_muscle_development | 0.82973653 |
| 120 | MP0005408_hypopigmentation | 0.81829287 |
| 121 | MP0000647_abnormal_sebaceous_gland | 0.81668971 |
| 122 | MP0002233_abnormal_nose_morphology | 0.81562041 |
| 123 | MP0009931_abnormal_skin_appearance | 0.81156280 |
| 124 | MP0004185_abnormal_adipocyte_glucose | 0.81036196 |
| 125 | MP0004858_abnormal_nervous_system | 0.80692706 |
| 126 | MP0000377_abnormal_hair_follicle | 0.79795915 |
| 127 | MP0002249_abnormal_larynx_morphology | 0.78719937 |
| 128 | MP0004233_abnormal_muscle_weight | 0.78669815 |
| 129 | MP0000049_abnormal_middle_ear | 0.78524109 |
| 130 | MP0005395_other_phenotype | 0.78456486 |
| 131 | MP0000685_abnormal_immune_system | 0.77865850 |
| 132 | MP0003950_abnormal_plasma_membrane | 0.77581847 |
| 133 | MP0002332_abnormal_exercise_endurance | 0.77237537 |
| 134 | MP0002132_abnormal_respiratory_system | 0.76600471 |
| 135 | MP0000767_abnormal_smooth_muscle | 0.76564297 |
| 136 | MP0003806_abnormal_nucleotide_metabolis | 0.76054007 |
| 137 | MP0000003_abnormal_adipose_tissue | 0.75050771 |
| 138 | MP0001348_abnormal_lacrimal_gland | 0.74137494 |
| 139 | MP0001851_eye_inflammation | 0.73667437 |
| 140 | MP0005375_adipose_tissue_phenotype | 0.66217894 |
| 141 | MP0000534_abnormal_ureter_morphology | 0.63922478 |
| 142 | MP0009643_abnormal_urine_homeostasis | 0.63576149 |
| 143 | MP0005595_abnormal_vascular_smooth | 0.62100213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Epiphyseal dysplasia (HP:0002656) | 7.00877331 |
| 2 | Vitreoretinal degeneration (HP:0000655) | 6.69345665 |
| 3 | Irregular epiphyses (HP:0010582) | 6.26631505 |
| 4 | Cupped ribs (HP:0000887) | 5.28934800 |
| 5 | Abnormal tarsal ossification (HP:0008369) | 4.97099496 |
| 6 | Hypoplastic ischia (HP:0003175) | 4.63626280 |
| 7 | Neonatal short-limb short stature (HP:0008921) | 4.33830977 |
| 8 | Flat capital femoral epiphysis (HP:0003370) | 4.27928172 |
| 9 | Abnormality of the ischium (HP:0003174) | 4.16736911 |
| 10 | Flat acetabular roof (HP:0003180) | 4.13562521 |
| 11 | Small epiphyses (HP:0010585) | 4.01456572 |
| 12 | Right ventricular cardiomyopathy (HP:0011663) | 3.93322926 |
| 13 | Delayed epiphyseal ossification (HP:0002663) | 3.90585958 |
| 14 | Atrophic scars (HP:0001075) | 3.83618636 |
| 15 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 3.75209550 |
| 16 | Protrusio acetabuli (HP:0003179) | 3.73059992 |
| 17 | Arthropathy (HP:0003040) | 3.69557318 |
| 18 | Abnormal foot bone ossification (HP:0010675) | 3.60446202 |
| 19 | Genu varum (HP:0002970) | 3.52177078 |
| 20 | Interstitial pulmonary disease (HP:0006530) | 3.30482323 |
| 21 | Metaphyseal cupping (HP:0003021) | 3.28958101 |
| 22 | Alopecia of scalp (HP:0002293) | 3.22554819 |
| 23 | Arterial tortuosity (HP:0005116) | 3.19051159 |
| 24 | Metaphyseal irregularity (HP:0003025) | 3.17303610 |
| 25 | Vascular tortuosity (HP:0004948) | 3.14467469 |
| 26 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 3.10345969 |
| 27 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.05879161 |
| 28 | Abnormal vertebral ossification (HP:0100569) | 3.02562969 |
| 29 | Osteoarthritis (HP:0002758) | 2.99509369 |
| 30 | Onycholysis (HP:0001806) | 2.97163369 |
| 31 | Deep venous thrombosis (HP:0002625) | 2.94907729 |
| 32 | Protuberant abdomen (HP:0001538) | 2.92243804 |
| 33 | Flattened epiphyses (HP:0003071) | 2.90541671 |
| 34 | Abnormality of the vertebral endplates (HP:0005106) | 2.86600581 |
| 35 | Abnormality of femoral epiphyses (HP:0006499) | 2.86190699 |
| 36 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.86190699 |
| 37 | Cervical subluxation (HP:0003308) | 2.85759150 |
| 38 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.80633232 |
| 39 | Absent frontal sinuses (HP:0002688) | 2.80165565 |
| 40 | Abnormality of incisor morphology (HP:0011063) | 2.76068750 |
| 41 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 2.73813096 |
| 42 | Milia (HP:0001056) | 2.71013839 |
| 43 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.69826315 |
| 44 | Abnormality of carpal bone ossification (HP:0006257) | 2.69224222 |
| 45 | Natal tooth (HP:0000695) | 2.68852177 |
| 46 | Mitral stenosis (HP:0001718) | 2.67286157 |
| 47 | Fragile skin (HP:0001030) | 2.66868769 |
| 48 | Short femoral neck (HP:0100864) | 2.65680263 |
| 49 | Follicular hyperkeratosis (HP:0007502) | 2.64619116 |
| 50 | Absent epiphyses (HP:0010577) | 2.60798477 |
| 51 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.60798477 |
| 52 | Thick nail (HP:0001805) | 2.60765282 |
| 53 | Stillbirth (HP:0003826) | 2.60202386 |
| 54 | Plantar hyperkeratosis (HP:0007556) | 2.56034498 |
| 55 | Aortic dissection (HP:0002647) | 2.54219899 |
| 56 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.51907738 |
| 57 | Metaphyseal dysplasia (HP:0100255) | 2.51817177 |
| 58 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.50041742 |
| 59 | Myocardial infarction (HP:0001658) | 2.47992687 |
| 60 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.45285527 |
| 61 | Fibular hypoplasia (HP:0003038) | 2.44757829 |
| 62 | Irregular vertebral endplates (HP:0003301) | 2.44607969 |
| 63 | Vascular calcification (HP:0004934) | 2.43673047 |
| 64 | Abnormality of complement system (HP:0005339) | 2.43556306 |
| 65 | Short nail (HP:0001799) | 2.43092173 |
| 66 | Thin ribs (HP:0000883) | 2.42351555 |
| 67 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.42350459 |
| 68 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.42350459 |
| 69 | Abnormality of glycolipid metabolism (HP:0010969) | 2.42350459 |
| 70 | Fragile nails (HP:0001808) | 2.41344954 |
| 71 | Coxa vara (HP:0002812) | 2.38291549 |
| 72 | Enlarged epiphyses (HP:0010580) | 2.37046948 |
| 73 | Abnormality of the femoral head (HP:0003368) | 2.36567052 |
| 74 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.34092139 |
| 75 | Vertebral hypoplasia (HP:0008417) | 2.34092139 |
| 76 | Complement deficiency (HP:0004431) | 2.33473233 |
| 77 | Distal lower limb muscle weakness (HP:0009053) | 2.32392399 |
| 78 | Nail dystrophy (HP:0008404) | 2.32390682 |
| 79 | Neurofibrillary tangles (HP:0002185) | 2.31307380 |
| 80 | Systemic lupus erythematosus (HP:0002725) | 2.31240627 |
| 81 | Cardiovascular calcification (HP:0011915) | 2.29428663 |
| 82 | Hypoplastic scapulae (HP:0000882) | 2.28972181 |
| 83 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 2.28972181 |
| 84 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.28921923 |
| 85 | Beaking of vertebral bodies (HP:0004568) | 2.25026772 |
| 86 | Sparse eyelashes (HP:0000653) | 2.22396230 |
| 87 | Barrel-shaped chest (HP:0001552) | 2.21839266 |
| 88 | Popliteal pterygium (HP:0009756) | 2.21265051 |
| 89 | Pterygium (HP:0001059) | 2.20526416 |
| 90 | Glucose intolerance (HP:0000833) | 2.19931179 |
| 91 | Thoracolumbar scoliosis (HP:0002944) | 2.19682136 |
| 92 | Advanced eruption of teeth (HP:0006288) | 2.17779508 |
| 93 | Mild short stature (HP:0003502) | 2.17192826 |
| 94 | Pili torti (HP:0003777) | 2.16534768 |
| 95 | Aortic aneurysm (HP:0004942) | 2.15958878 |
| 96 | Platyspondyly (HP:0000926) | 2.15443260 |
| 97 | Hydroxyprolinuria (HP:0003080) | 2.15344469 |
| 98 | Abnormality of proline metabolism (HP:0010907) | 2.15344469 |
| 99 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.14741459 |
| 100 | Abnormality of the Achilles tendon (HP:0005109) | 2.12391205 |
| 101 | Nuclear cataract (HP:0100018) | 2.12004848 |
| 102 | Abnormality of nail color (HP:0100643) | 2.11766776 |
| 103 | Upper limb amyotrophy (HP:0009129) | 2.09963635 |
| 104 | Distal upper limb amyotrophy (HP:0007149) | 2.09963635 |
| 105 | Hypoplasia of dental enamel (HP:0006297) | 2.09194385 |
| 106 | Abnormality of the frontal sinuses (HP:0002687) | 2.08291928 |
| 107 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.07093881 |
| 108 | Osteolytic defects of the hand bones (HP:0009699) | 2.06745355 |
| 109 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.06745355 |
| 110 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.06729365 |
| 111 | Abnormality of the 2nd finger (HP:0004100) | 2.06395659 |
| 112 | Ovoid vertebral bodies (HP:0003300) | 2.05630295 |
| 113 | Ankle contracture (HP:0006466) | 2.05436432 |
| 114 | Distal lower limb amyotrophy (HP:0008944) | 2.05102632 |
| 115 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.04594841 |
| 116 | Axonal loss (HP:0003447) | 2.03974976 |
| 117 | Palmoplantar hyperkeratosis (HP:0000972) | 2.03177433 |
| 118 | Intrahepatic cholestasis (HP:0001406) | 2.01876763 |
| 119 | Spinal rigidity (HP:0003306) | 2.01261805 |
| 120 | Premature rupture of membranes (HP:0001788) | 2.00736788 |
| 121 | Achilles tendon contracture (HP:0001771) | 2.00431448 |
| 122 | Wormian bones (HP:0002645) | 1.99156461 |
| 123 | Abnormality of the lumbar spine (HP:0100712) | 1.98904921 |
| 124 | Abnormal hand bone ossification (HP:0010660) | 1.98557576 |
| 125 | Glomerulonephritis (HP:0000099) | 1.97245829 |
| 126 | Dysostosis multiplex (HP:0000943) | 1.96615018 |
| 127 | Limited elbow extension (HP:0001377) | 1.96592003 |
| 128 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.95916108 |
| 129 | Vacuolated lymphocytes (HP:0001922) | 1.95301524 |
| 130 | Abnormality of the pubic bones (HP:0003172) | 1.94480733 |
| 131 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.93830266 |
| 132 | Xanthomatosis (HP:0000991) | 1.93109676 |
| 133 | Abnormal hair laboratory examination (HP:0003328) | 1.92916374 |
| 134 | Patent foramen ovale (HP:0001655) | 1.92575656 |
| 135 | Abnormal ossification of hand bones (HP:0005921) | 1.91281919 |
| 136 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.90074841 |
| 137 | Cerebral inclusion bodies (HP:0100314) | 1.90062041 |
| 138 | Lip pit (HP:0100267) | 1.89985656 |
| 139 | Eczematoid dermatitis (HP:0000976) | 1.89501047 |
| 140 | Glossoptosis (HP:0000162) | 1.89398108 |
| 141 | Mixed hearing impairment (HP:0000410) | 1.89015862 |
| 142 | Elbow flexion contracture (HP:0002987) | 1.88807527 |
| 143 | Abnormal cartilage morphology (HP:0002763) | 1.86474689 |
| 144 | Mucopolysacchariduria (HP:0008155) | 1.86465822 |
| 145 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.86465822 |
| 146 | Spondylolisthesis (HP:0003302) | 1.85427339 |
| 147 | Focal segmental glomerulosclerosis (HP:0000097) | 1.85357804 |
| 148 | Vertebral compression fractures (HP:0002953) | 1.83887816 |
| 149 | Spinal cord compression (HP:0002176) | 1.83807826 |
| 150 | Acanthosis nigricans (HP:0000956) | 1.83703380 |
| 151 | Ulnar bowing (HP:0003031) | 1.83659784 |
| 152 | Long clavicles (HP:0000890) | 1.83631491 |
| 153 | Aplasia involving bones of the extremities (HP:0009825) | 1.83018238 |
| 154 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.83018238 |
| 155 | Aplasia of the phalanges of the hand (HP:0009802) | 1.83018238 |
| 156 | Respiratory distress (HP:0002098) | 1.81983722 |
| 157 | Short middle phalanx of finger (HP:0005819) | 1.81216113 |
| 158 | Vertebral clefting (HP:0008428) | 1.80655627 |
| 159 | Trismus (HP:0000211) | 1.80596407 |
| 160 | Selective tooth agenesis (HP:0001592) | 1.80452035 |
| 161 | Palmar hyperkeratosis (HP:0010765) | 1.79893895 |
| 162 | Steatorrhea (HP:0002570) | 1.79799234 |
| 163 | Blue sclerae (HP:0000592) | 1.79361116 |
| 164 | Chronic bronchitis (HP:0004469) | 1.79316018 |
| 165 | Exostoses (HP:0100777) | 1.79286808 |
| 166 | Hypoalphalipoproteinemia (HP:0003233) | 1.79109626 |
| 167 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.78891888 |
| 168 | Submucous cleft hard palate (HP:0000176) | 1.77994119 |
| 169 | Abnormality of the acetabulum (HP:0003170) | 1.76795731 |
| 170 | Increased connective tissue (HP:0009025) | 1.75593381 |
| 171 | Nephritis (HP:0000123) | 1.75544450 |
| 172 | Pulmonary artery stenosis (HP:0004415) | 1.75504663 |
| 173 | Abnormality of dentin (HP:0010299) | 1.74116764 |
| 174 | Abnormal blistering of the skin (HP:0008066) | 1.74038620 |
| 175 | Fat malabsorption (HP:0002630) | 1.73987736 |
| 176 | Thin bony cortex (HP:0002753) | 1.73814305 |
| 177 | Ankyloglossia (HP:0010296) | 1.73582524 |
| 178 | 11 pairs of ribs (HP:0000878) | 1.73020792 |
| 179 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.72141090 |
| 180 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.72141090 |
| 181 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.72141090 |
| 182 | Abnormality of the middle phalanges of the hand (HP:0009833) | 1.72125100 |
| 183 | Glomerulosclerosis (HP:0000096) | 1.70040665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K3 | 4.52609331 |
| 2 | MST4 | 3.76102575 |
| 3 | ERBB3 | 3.64453258 |
| 4 | PBK | 3.45876249 |
| 5 | MAP3K14 | 3.20359452 |
| 6 | LATS2 | 2.73276204 |
| 7 | BMPR2 | 2.72880499 |
| 8 | DDR2 | 2.72543443 |
| 9 | STK38L | 2.64238673 |
| 10 | EPHA2 | 2.55821341 |
| 11 | MUSK | 2.51408379 |
| 12 | IRAK3 | 2.47106849 |
| 13 | PIM2 | 2.38377128 |
| 14 | STK24 | 2.26374336 |
| 15 | TRPM7 | 2.17811232 |
| 16 | PAK4 | 2.10765373 |
| 17 | PTK2 | 2.04723331 |
| 18 | MYLK | 1.92255247 |
| 19 | MST1R | 1.84734609 |
| 20 | IKBKB | 1.83355332 |
| 21 | PDGFRA | 1.82002576 |
| 22 | MAP3K12 | 1.79573001 |
| 23 | MKNK2 | 1.78688635 |
| 24 | EPHA3 | 1.76609036 |
| 25 | TBK1 | 1.72438567 |
| 26 | TRIB3 | 1.69188087 |
| 27 | PRKG2 | 1.64415144 |
| 28 | TYK2 | 1.58932462 |
| 29 | MKNK1 | 1.55570272 |
| 30 | IKBKE | 1.53477218 |
| 31 | ZAK | 1.50649081 |
| 32 | ERN1 | 1.48527867 |
| 33 | CHUK | 1.36677320 |
| 34 | MAPKAPK3 | 1.35824288 |
| 35 | LIMK1 | 1.33910433 |
| 36 | SMG1 | 1.33733078 |
| 37 | NEK9 | 1.32969730 |
| 38 | FGFR4 | 1.26599811 |
| 39 | BMX | 1.23020311 |
| 40 | NTRK1 | 1.21283581 |
| 41 | TTN | 1.18920323 |
| 42 | NUAK1 | 1.17832942 |
| 43 | MET | 1.14116577 |
| 44 | STK3 | 1.13582093 |
| 45 | EPHB2 | 1.13302391 |
| 46 | PIM1 | 1.10887945 |
| 47 | SIK3 | 1.07888506 |
| 48 | ARAF | 1.04508067 |
| 49 | NME1 | 1.04149329 |
| 50 | ICK | 1.03434909 |
| 51 | ERBB4 | 1.02930475 |
| 52 | MAP3K9 | 1.02498484 |
| 53 | SIK1 | 1.02482463 |
| 54 | JAK3 | 1.02481212 |
| 55 | IRAK4 | 0.99472681 |
| 56 | PLK2 | 0.98797193 |
| 57 | NEK6 | 0.98068277 |
| 58 | LATS1 | 0.96270943 |
| 59 | FGFR3 | 0.95233261 |
| 60 | RIPK4 | 0.94105204 |
| 61 | STK38 | 0.92172668 |
| 62 | JAK1 | 0.91682320 |
| 63 | TAOK2 | 0.90904905 |
| 64 | EIF2AK2 | 0.87944888 |
| 65 | BMPR1B | 0.86330838 |
| 66 | MAP3K11 | 0.86313885 |
| 67 | EIF2AK1 | 0.85680325 |
| 68 | FRK | 0.84685636 |
| 69 | SGK2 | 0.84100783 |
| 70 | LMTK2 | 0.83087393 |
| 71 | RPS6KA4 | 0.80495561 |
| 72 | MAP3K5 | 0.76803232 |
| 73 | IRAK1 | 0.74454021 |
| 74 | ABL2 | 0.72774291 |
| 75 | PDK2 | 0.72023134 |
| 76 | NLK | 0.70849654 |
| 77 | MAPK7 | 0.69895712 |
| 78 | TESK1 | 0.68848295 |
| 79 | STK10 | 0.68781379 |
| 80 | PKN2 | 0.68566217 |
| 81 | PDGFRB | 0.68423303 |
| 82 | MAP2K3 | 0.68125124 |
| 83 | PAK2 | 0.65572658 |
| 84 | PTK6 | 0.64995490 |
| 85 | CDC42BPA | 0.64300763 |
| 86 | ILK | 0.64294344 |
| 87 | STK39 | 0.63831768 |
| 88 | SCYL2 | 0.61096886 |
| 89 | BLK | 0.60392454 |
| 90 | BCR | 0.59187963 |
| 91 | MARK3 | 0.59157570 |
| 92 | SGK3 | 0.58935529 |
| 93 | FER | 0.56366226 |
| 94 | ABL1 | 0.56196047 |
| 95 | EPHB1 | 0.56175870 |
| 96 | LRRK2 | 0.55813892 |
| 97 | GSK3A | 0.55359446 |
| 98 | ROCK1 | 0.54478917 |
| 99 | EIF2AK3 | 0.54385187 |
| 100 | DMPK | 0.53557639 |
| 101 | TGFBR2 | 0.52019294 |
| 102 | TESK2 | 0.51092779 |
| 103 | NME2 | 0.50163915 |
| 104 | PRKCE | 0.49919107 |
| 105 | MELK | 0.49660269 |
| 106 | MTOR | 0.49447785 |
| 107 | CDK12 | 0.47728971 |
| 108 | PRKCI | 0.47358653 |
| 109 | CDK6 | 0.46641330 |
| 110 | ROCK2 | 0.45852767 |
| 111 | PIK3CG | 0.45037955 |
| 112 | MAP3K1 | 0.44439695 |
| 113 | CSK | 0.43281895 |
| 114 | MAP3K8 | 0.42633300 |
| 115 | TXK | 0.41963745 |
| 116 | FLT3 | 0.41274465 |
| 117 | RPS6KB2 | 0.40538069 |
| 118 | DYRK1A | 0.40280312 |
| 119 | MOS | 0.40218771 |
| 120 | MAP3K6 | 0.38971092 |
| 121 | BRSK2 | 0.38713831 |
| 122 | FGFR1 | 0.38487169 |
| 123 | TEC | 0.38386194 |
| 124 | DAPK3 | 0.38223635 |
| 125 | CDK8 | 0.38169011 |
| 126 | PRKD2 | 0.37735604 |
| 127 | MAPKAPK2 | 0.37531191 |
| 128 | CAMK2G | 0.36925485 |
| 129 | * PRKCD | 0.36266263 |
| 130 | RPS6KA2 | 0.36116900 |
| 131 | MAP2K1 | 0.35636620 |
| 132 | MAPK15 | 0.35431280 |
| 133 | EEF2K | 0.35259825 |
| 134 | AKT3 | 0.35166243 |
| 135 | PIK3CA | 0.35107742 |
| 136 | HCK | 0.34171588 |
| 137 | MAPK4 | 0.33657003 |
| 138 | IGF1R | 0.33242945 |
| 139 | JAK2 | 0.33174486 |
| 140 | PRPF4B | 0.31176030 |
| 141 | GRK7 | 0.30264134 |
| 142 | AKT2 | 0.29742334 |
| 143 | RPS6KA5 | 0.28621374 |
| 144 | TAOK1 | 0.28489551 |
| 145 | RIPK1 | 0.28328356 |
| 146 | STK4 | 0.28053701 |
| 147 | MAP3K2 | 0.27809353 |
| 148 | MAPK12 | 0.27604877 |
| 149 | IRAK2 | 0.27568588 |
| 150 | SGK494 | 0.27273844 |
| 151 | SGK223 | 0.27273844 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.30012493 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.00709156 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.70909792 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.41707268 |
| 5 | Malaria_Homo sapiens_hsa05144 | 2.21873864 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.21754213 |
| 7 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.20998588 |
| 8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.18704060 |
| 9 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.17212773 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.00101230 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.97141455 |
| 12 | * ECM-receptor interaction_Homo sapiens_hsa04512 | 1.96292719 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.88756974 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.77070962 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.76791784 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.74661883 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.72247466 |
| 18 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.70586126 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.67556067 |
| 20 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.65036787 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.64555039 |
| 22 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.62623343 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.61239436 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.55615145 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.55107301 |
| 26 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.54655381 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.53371600 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.46178095 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.44282913 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40866799 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.39391347 |
| 32 | Tight junction_Homo sapiens_hsa04530 | 1.39310696 |
| 33 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.37811769 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.37735121 |
| 35 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.36937679 |
| 36 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.31416361 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.30867869 |
| 38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.29732671 |
| 39 | Allograft rejection_Homo sapiens_hsa05330 | 1.28701703 |
| 40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.26416773 |
| 41 | Thyroid cancer_Homo sapiens_hsa05216 | 1.25928305 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.22374541 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 1.16501505 |
| 44 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.15849286 |
| 45 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.15773403 |
| 46 | Histidine metabolism_Homo sapiens_hsa00340 | 1.13321971 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12063257 |
| 48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.11045424 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 1.09898560 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 1.01688715 |
| 51 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.99110413 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.98936093 |
| 53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.98898589 |
| 54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.98654277 |
| 55 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.98565639 |
| 56 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.98089477 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.96311618 |
| 58 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.96190447 |
| 59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.95807455 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93404716 |
| 61 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.91932185 |
| 62 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.91707844 |
| 63 | Tuberculosis_Homo sapiens_hsa05152 | 0.91132226 |
| 64 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.91007656 |
| 65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.90718337 |
| 66 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.90276419 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89853665 |
| 68 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.87770426 |
| 69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.87470752 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 0.87446729 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.87032885 |
| 72 | Measles_Homo sapiens_hsa05162 | 0.86689443 |
| 73 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.86413608 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.86362183 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.85540787 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.85243399 |
| 77 | Apoptosis_Homo sapiens_hsa04210 | 0.85229052 |
| 78 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84880145 |
| 79 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.83870007 |
| 80 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83504743 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.82644010 |
| 82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.80977777 |
| 83 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.80781729 |
| 84 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.80037728 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79855641 |
| 86 | Salmonella infection_Homo sapiens_hsa05132 | 0.79133380 |
| 87 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.77362296 |
| 88 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76015890 |
| 89 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.75720141 |
| 90 | Asthma_Homo sapiens_hsa05310 | 0.75538949 |
| 91 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74299277 |
| 92 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.74127143 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.72669584 |
| 94 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72528699 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70808017 |
| 96 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.70434353 |
| 97 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70316468 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | 0.69777313 |
| 99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67642645 |
| 100 | Bile secretion_Homo sapiens_hsa04976 | 0.66918864 |
| 101 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65404036 |
| 102 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.64118050 |
| 103 | Focal adhesion_Homo sapiens_hsa04510 | 0.62844062 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.61965052 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61933925 |
| 106 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.60589581 |
| 107 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59873454 |
| 108 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59225653 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58207053 |
| 110 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.57593520 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57542514 |
| 112 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56830701 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.56729845 |
| 114 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56084269 |
| 115 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54160583 |
| 116 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53535213 |
| 117 | Adherens junction_Homo sapiens_hsa04520 | 0.52956508 |
| 118 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52862193 |
| 119 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.51048365 |
| 120 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.49578899 |
| 121 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.47893385 |
| 122 | Prostate cancer_Homo sapiens_hsa05215 | 0.47343437 |
| 123 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46287536 |
| 124 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.45287628 |
| 125 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43910094 |
| 126 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.43214221 |
| 127 | Hepatitis B_Homo sapiens_hsa05161 | 0.42687635 |
| 128 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39525853 |
| 129 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38430316 |
| 130 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.38182614 |
| 131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37177158 |
| 132 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.35267808 |
| 133 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.35223414 |
| 134 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32266361 |
| 135 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.31806338 |
| 136 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.28942470 |
| 137 | Bladder cancer_Homo sapiens_hsa05219 | 0.28196485 |
| 138 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.28064132 |

